Best Thrombopoietin Receptor Agonist for anemia, aplastic
2 Thrombopoietin Receptor Agonist drugs indicated for anemia, aplastic, ranked by our independent rating. The current highest-rated is promacta. Compare them with all treatments for anemia, aplastic or the full Thrombopoietin Receptor Agonist class. Not medical advice — always consult a professional.
Top thrombopoietin receptor agonist for anemia, aplastic: 1. Promacta · 2. Promacta Kit
| # | Drug | Rating | Type | Typical price | |
|---|---|---|---|---|---|
| 1 | Promacta | 68/100 | Prescription | — | View → |
| 2 | Promacta Kit | 68/100 | Prescription | — | View → |
Full ranking · 2 drugs
Frequently asked
- What is the best thrombopoietin receptor agonist for anemia, aplastic?
- By our independent rating, promacta currently ranks highest among Thrombopoietin Receptor Agonist drugs used for anemia, aplastic. Ratings are based on FDA regulatory (recall-safety) data — always consult a professional.
- Which thrombopoietin receptor agonist drugs treat anemia, aplastic?
- pharmaranks lists 2 Thrombopoietin Receptor Agonist products indicated for anemia, aplastic, per FDA drug-label data — each independently rated and ranked above.
- How are these ranked?
- By our independent score, currently based on FDA regulatory recall-safety data (the methodology blends additional sources as they come online). See the How we rate page.